Olivier Litzka

Insider Reports History

Location
Radnor, PA
Signature
/s/ Adam Levy, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Olivier Litzka:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mineralys Therapeutics, Inc. Director Stock Option 22,000 22 May 2024 Direct

Insider Reports Filed by Olivier Litzka

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MLYS Mineralys Therapeutics, Inc. 22 May 2024 1 $0 4 Director 23 May 2024, 16:20
MLYS Mineralys Therapeutics, Inc. 27 Apr 2023 1 $0 4 Director 01 May 2023, 16:06
MLYS Mineralys Therapeutics, Inc. 09 Feb 2023 1 $0 4 Director 13 Feb 2023, 20:02
MLYS Mineralys Therapeutics, Inc. 09 Feb 2023 0 $0 3 Director 09 Feb 2023, 18:54